Skip to main content
VCbacked
Log inGet Started

Fountain Therapeutics

San Francisco, United States

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.

$15.0M raised
Nov 2021
Series A
BiotechnologyHealth CareTherapeutics

Top Investors

Khosla VenturesR42 GroupAlexandria Venture InvestmentsNan Fung Life SciencesEli Lilly & Company Foundation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fountain Therapeutics

How much funding has Fountain Therapeutics raised?
Fountain Therapeutics has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Who are Fountain Therapeutics's investors?
Fountain Therapeutics's investors include Khosla Ventures, R42 Group, Alexandria Venture Investments, Nan Fung Life Sciences, Eli Lilly & Company Foundation.
Where is Fountain Therapeutics headquartered?
Fountain Therapeutics is headquartered in San Francisco, United States.
What does Fountain Therapeutics do?
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
What stage is Fountain Therapeutics at?
Fountain Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fountain Therapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/fountain-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2021). Fountain Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/fountain-therapeutics
Wikipedia (cite web)
{{cite web |title=Fountain Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fountain-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K